English

EndoChoice Holdings, Inc.

EDGAR

Quarterly report (10-Q) · filed 2016-11-07

8 filing records in this dataset, filed from 2015-05-05 to 2016-11-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

19.2 million USD

2016 Q3 · USD

Exact inputs and evidence

Revenue: 19150000 USD Source

Operating margin

-82.04%

2016 Q3 · %

Exact inputs and evidence

Operating Income: -15711000 USD Source
Revenue: 19150000 USD Source

Operating cash flow

-10.4 million USD

2016 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -36793000 USD Source
Operating Cash Flow: -26378000 USD Source

Free cash flow

-12.9 million USD

2016 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -36793000 USD Source
Operating Cash Flow: -26378000 USD Source
Capital Expenditure: 7114000 USD Source
Capital Expenditure: 4604000 USD Source

Cash and cash equivalents: 15.1 million USD 2016-09-30 Source
Exact value

15148000 USD
Long-term debt including current maturities: 42.6 million USD 2015-12-31
Exact inputs and evidence

42643000 USD

Long-term debt including current maturities: 42643000 USD Source
Shares outstanding: 25.4 million shares 2016-09-30 Source
Exact value

25393206 shares

Reported share-count change

2.42% · 599 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

24793841 shares · 2015-09-30· Source
25393206 shares · 2016-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

75.4 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Revenue: 18547000 USD · 2015-10-01 – 2015-12-31 Source
Revenue: 18462000 USD · 2016-01-01 – 2016-03-31 Source
Revenue: 19252000 USD · 2016-04-01 – 2016-06-30 Source
Revenue: 19150000 USD · 2016-07-01 – 2016-09-30 Source

Net income

-72.2 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Net income: -13045000 USD · 2015-10-01 – 2015-12-31 Source
Net income: -17062000 USD · 2016-01-01 – 2016-03-31 Source
Net income: -24685000 USD · 2016-04-01 – 2016-06-30 Source
Net income: -17363000 USD · 2016-07-01 – 2016-09-30 Source

Operating cash flow

-48.3 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Operating cash flow: -42625000 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -31135000 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -14345000 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -26378000 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -14345000 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -36793000 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -26378000 USD · 2016-01-01 – 2016-06-30 Source

Capital expenditure

10.7 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Capital expenditure: 8603000 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 4977000 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 2840000 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 4604000 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 2840000 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 7114000 USD · 2016-01-01 – 2016-09-30 Source
Capital expenditure: 4604000 USD · 2016-01-01 – 2016-06-30 Source

Free cash flow

-59 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Operating cash flow: -42625000 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -31135000 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -14345000 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -26378000 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -14345000 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -36793000 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -26378000 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 8603000 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 4977000 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 2840000 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 4604000 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 2840000 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 7114000 USD · 2016-01-01 – 2016-09-30 Source
Capital expenditure: 4604000 USD · 2016-01-01 – 2016-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-11-07.

Financial data available through: 2015-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2015-12-31
Operating income: 3 of 11 periods available· newest 2015-12-31
Net income: 3 of 11 periods available· newest 2015-12-31
Operating cash flow: 3 of 11 periods available· newest 2015-12-31
Capital expenditure: 3 of 11 periods available· newest 2015-12-31
Total assets: 2 of 11 periods available· newest 2015-12-31
Total liabilities: 2 of 11 periods available· newest 2015-12-31
Current assets: 2 of 11 periods available· newest 2015-12-31
Current liabilities: 2 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2015-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2015-12-31
Shares outstanding: 2 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+17.7%

Prior period

USD 61.42 million

2014-01-01 – 2014-12-31
Current period

USD 72.3 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

72300000 − 61419000 = 10881000 USD

61419000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
72300000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · EndoChoice Holdings, Inc. · 2015-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Year-over-year change in Revenue: 10881000 USD Concept: fundies:Revenue Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 72300000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#296583 Filing: 000162391916000051 Input fundies:Revenue: 61419000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#295230 Filing: 000162391916000051
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 5.74 million

Prior period

−USD 53.64 million

2014-01-01 – 2014-12-31
Current period

−USD 59.38 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-59384000 − -53644000 = -5740000 USD

-53644000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-59384000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · EndoChoice Holdings, Inc. · 2015-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Year-over-year change in Net income: -5740000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -59384000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#257212 Filing: 000162391916000051 Input fundies:NetIncome: -53644000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#256219 Filing: 000162391916000051
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 998,000

Prior period

−USD 43.62 million

2014-01-01 – 2014-12-31
Current period

−USD 42.63 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-42625000 − -43623000 = 998000 USD

-43623000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-42625000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · EndoChoice Holdings, Inc. · 2015-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Year-over-year change in Operating cash flow: 998000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -42625000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#255014 Filing: 000162391916000051 Input fundies:OperatingCashFlow: -43623000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#254802 Filing: 000162391916000051
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-13.9%

Prior period

USD 9.99 million

2014-01-01 – 2014-12-31
Current period

USD 8.6 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

8603000 − 9987000 = -1384000 USD

9987000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
8603000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · EndoChoice Holdings, Inc. · 2015-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Year-over-year change in Capital expenditure: -1384000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 8603000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#274429 Filing: 000162391916000051 Input fundies:CapitalExpenditure: 9987000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#274219 Filing: 000162391916000051
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2015-01-01 – 2015-12-31

Revenue USD 72.3 million 100% of revenue
Cost of revenue USD 43.75 million 61% of revenue
Operating expenses USD 73.57 million 102% of revenue
Other operating costs Derived USD 5.25 million 7.3% of revenue
Operating income −USD 50.26 million −70% of revenue
Tax, interest and other Derived USD 9.13 million 13% of revenue
Net income −USD 59.38 million −82% of revenue

Cash

Operating cash flow −USD 42.63 million −59% of revenue
Capital expenditure USD 8.6 million 12% of revenue
Free cash flow Derived −USD 51.23 million −71% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2013 Operating loss: operating costs were 150% of revenue.
2014 Operating loss: operating costs were 177% of revenue.
2015 Operating loss: operating costs were 170% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2013 2013-01-01 – 2013-12-31	50891000	76590000 Derived	-25699000	-1781000 Derived	-23918000	-30398000 Derived	Source 2013-01-01 – 2013-12-31: 50891000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -25699000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -23918000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -25409000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 4989000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	61419000	108634000 Derived	-47215000	6429000 Derived	-53644000	-53610000 Derived	Source 2014-01-01 – 2014-12-31: 61419000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -47215000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -53644000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -43623000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 9987000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	72300000	122556000 Derived	-50256000	9128000 Derived	-59384000	-51228000 Derived	Source 2015-01-01 – 2015-12-31: 72300000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -50256000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -59384000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -42625000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 8603000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 72.3M 2015

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Revenue	50891000	Revenue: 50891000 Open source
20142014-12-31	Revenue	61419000	Revenue: 61419000 Open source
20152015-12-31	Revenue	72300000	Revenue: 72300000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

17.7% 2015

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Year over year	No prior comparable period	Revenue: 50891000 Open source
20142014-12-31	Year over year	20.7%	Revenue: 61419000 Open source Revenue: 50891000 Open source
20152015-12-31	Year over year	17.7%	Revenue: 72300000 Open source Revenue: 61419000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -69.5% 2015

Net margin -82.1% 2015

Free cash flow margin -70.9% 2015

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Operating margin	-50.5%	Operating Income: -25699000 Open source Revenue: 50891000 Open source
20142014-12-31	Operating margin	-76.9%	Operating Income: -47215000 Open source Revenue: 61419000 Open source
20152015-12-31	Operating margin	-69.5%	Operating Income: -50256000 Open source Revenue: 72300000 Open source
20132013-12-31	Net margin	-47%	Net Income: -23918000 Open source Revenue: 50891000 Open source
20142014-12-31	Net margin	-87.3%	Net Income: -53644000 Open source Revenue: 61419000 Open source
20152015-12-31	Net margin	-82.1%	Net Income: -59384000 Open source Revenue: 72300000 Open source
20132013-12-31	Free cash flow margin	-59.7%	Revenue: 50891000 Open source Operating Cash Flow: -25409000 Open source Capital Expenditure: 4989000 Open source
20142014-12-31	Free cash flow margin	-87.3%	Revenue: 61419000 Open source Operating Cash Flow: -43623000 Open source Capital Expenditure: 9987000 Open source
20152015-12-31	Free cash flow margin	-70.9%	Revenue: 72300000 Open source Operating Cash Flow: -42625000 Open source Capital Expenditure: 8603000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -42.6M 2015

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Operating cash flow	-25409000	Operating Cash Flow: -25409000 Open source
20142014-12-31	Operating cash flow	-43623000	Operating Cash Flow: -43623000 Open source
20152015-12-31	Operating cash flow	-42625000	Operating Cash Flow: -42625000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -51.2M 2015

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Free cash flow	-30398000	Operating Cash Flow: -25409000 Open source Capital Expenditure: 4989000 Open source
20142014-12-31	Free cash flow	-53610000	Operating Cash Flow: -43623000 Open source Capital Expenditure: 9987000 Open source
20152015-12-31	Free cash flow	-51228000	Operating Cash Flow: -42625000 Open source Capital Expenditure: 8603000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

39.6% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2013-12-31	Liabilities / assets	Not reported	No source recorded
20142014-12-31	Liabilities / assets	69.8%	Total Liabilities: 60570000 Open source Total Assets: 86809000 Open source
20152015-12-31	Liabilities / assets	39.6%	Total Liabilities: 65045000 Open source Total Assets: 164338000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.31× 2015

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2013-12-31	Current assets / current liabilities	Not reported	No source recorded
20142014-12-31	Current assets / current liabilities	2.64×	Current Assets: 39110000 Open source Current Liabilities: 14788000 Open source
20152015-12-31	Current assets / current liabilities	5.31×	Current Assets: 98366000 Open source Current Liabilities: 18534000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2013-01-01 – 2013-12-31	−USD 23.92 million Exact value Exact value: -23918000 USD 2013-01-01 – 2013-12-31: -23918000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EndoChoice Holdings, Inc. · 2013-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Net Income: -23918000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23918000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#255226 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.	−USD 25.41 million Exact value Exact value: -25409000 USD 2013-01-01 – 2013-12-31: -25409000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EndoChoice Holdings, Inc. · 2013-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Operating Cash Flow: -25409000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25409000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#254590 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.	USD 4.99 million Exact value Exact value: 4989000 USD 2013-01-01 – 2013-12-31: 4989000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EndoChoice Holdings, Inc. · 2013-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Capital Expenditure: 4989000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4989000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#274009 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.	−USD 30.4 million Calculation and evidence -25409000 − 4989000 USD Exact free cash flow: -30398000 USD 2013-01-01 – 2013-12-31: -25409000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 4989000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EndoChoice Holdings, Inc. · 2013-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Free cash flow: -30398000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25409000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#254590 Filing: 000162391916000051 Input fundies:CapitalExpenditure: 4989000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#274009 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 53.64 million Exact value Exact value: -53644000 USD 2014-01-01 – 2014-12-31: -53644000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EndoChoice Holdings, Inc. · 2014-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Net Income: -53644000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53644000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#256219 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.	−USD 43.62 million Exact value Exact value: -43623000 USD 2014-01-01 – 2014-12-31: -43623000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EndoChoice Holdings, Inc. · 2014-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Operating Cash Flow: -43623000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -43623000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#254802 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.	USD 9.99 million Exact value Exact value: 9987000 USD 2014-01-01 – 2014-12-31: 9987000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EndoChoice Holdings, Inc. · 2014-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Capital Expenditure: 9987000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9987000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#274219 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.	−USD 53.61 million Calculation and evidence -43623000 − 9987000 USD Exact free cash flow: -53610000 USD 2014-01-01 – 2014-12-31: -43623000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 9987000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EndoChoice Holdings, Inc. · 2014-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Free cash flow: -53610000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -43623000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#254802 Filing: 000162391916000051 Input fundies:CapitalExpenditure: 9987000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#274219 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 59.38 million Exact value Exact value: -59384000 USD 2015-01-01 – 2015-12-31: -59384000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EndoChoice Holdings, Inc. · 2015-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Net Income: -59384000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -59384000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#257212 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.	−USD 42.63 million Exact value Exact value: -42625000 USD 2015-01-01 – 2015-12-31: -42625000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EndoChoice Holdings, Inc. · 2015-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Operating Cash Flow: -42625000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -42625000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#255014 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.	USD 8.6 million Exact value Exact value: 8603000 USD 2015-01-01 – 2015-12-31: 8603000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EndoChoice Holdings, Inc. · 2015-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Capital Expenditure: 8603000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8603000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#274429 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.	−USD 51.23 million Calculation and evidence -42625000 − 8603000 USD Exact free cash flow: -51228000 USD 2015-01-01 – 2015-12-31: -42625000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 8603000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EndoChoice Holdings, Inc. · 2015-12-31 EndoChoice Holdings, Inc. (edgar:1623919) Free cash flow: -51228000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1623919?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -42625000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#255014 Filing: 000162391916000051 Input fundies:CapitalExpenditure: 8603000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1623919/000162391916000051/gi-20151231.xml#274429 Filing: 000162391916000051 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

8 filings · 802 latest values · 802 originally reported values

Dataset published 2026-11-07. Source filing dates and reporting periods are shown separately.

Identifiers: 0001623919, 1623919, edgar:1623919

Also known as ECPM Holdings, LLC, EndoChoice Holdings, Inc.

EndoChoice Holdings, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2015 2015-01-01 – 2015-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation